Active Ingredient History

  • Now
Torcetrapib was a drug being developed to treat hypercholesterolemia and prevent cardiovascular disease. Its development was halted in 2006 when phase III studies showed excessive all-cause mortality in the treatment group receiving a combination of atorvastatin (Lipitor) and torcetrapib.   Wikipedia

  • SMILES: CCOC(=O)N1[C@H](CC)C[C@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)OC)c3cc(ccc13)C(F)(F)F
  • Mol. Mass: 600.48
  • ALogP: 8.2
  • ChEMBL Molecule:
More Chemistry
cp529414 | cp 529414 | cp 529,414 | cp-529414 | cp-529,414 | cp529,414 | torcetrapib


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue